Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

PRESS DIGEST- New York Times business news - June 1

Published 2016-06-01, 01:57 a/m
© Reuters.  PRESS DIGEST- New York Times business news - June 1
PSON
-
PARA
-
AGN_pa
-
BHC
-
VOWG_p
-

June 1 (Reuters) - The following are the top stories on the
New York Times business pages. Reuters has not verified these
stories and does not vouch for their accuracy.

- Shari Redstone made one of her boldest statements on
Tuesday in the battle over her father's $40 billion media
empire. Redstone underscored that she had no desire to manage
Viacom VIAB.O nor to lead its board, but said she wanted "the
best management in place" and "strong, independent directors who
will properly oversee that management".

The billionaire activist investor Carl Icahn disclosed in
a statement that he has bought "a large position" in Allergan (NYSE:AGN_pa)
AGN.N , which is technically headquartered in Dublin. He didn't
detail how large of a stake or when the purchase was made.

Volkswagen VOWG_p.DE reported a 19 percent drop in its
quarterly profit. However, the quarterly profit of $2.7 billion,
was better than what analysts had forecasted. It was also an
improvement from the loss in the last three months of 2015.

Michael Pearson (LON:PSON), the former chief executive of Valeant
Pharmaceuticals International VRX.TO who departed in early May
during a series of investigations into the company's business
practices, will receive a $9 million severance payment and
continue working as a consultant through 2017, Valeant said
Tuesday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.